CHRS NASDAQ
Coherus Oncology, Inc.
1W: -3.7%
1M: -12.8%
3M: -3.7%
YTD: +14.6%
1Y: +92.4%
3Y: -69.7%
5Y: -89.6%
$1.61
+0.04 (+2.55%)
Weekly Expected Move ±11.0%
$1
$1
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$47M
Revenue
-76.3% YoY
$187M
Net Income
+242.8% YoY
$-171M
Free Cash Flow
-34214.6% YoY
61.9%
Gross Margin
-293.7%
Op. Margin
-308.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-527.0%
ROA52.9%
ROIC191.8%
Valuation
P/E-1.4
P/B2.8
EV/EBITDA-0.6
Leverage
Debt/Equity0.66
Current Ratio1.46
Interest Cov.-18.5x
Quality Scores
Piotroski F3/9
Altman Z-8.44
Beneish M3.51